American Healthcare REIT Inc (AHR) is overvalued and Sabra Healthcare REIT Inc (SBRA) is overvalued.
Both trade above our estimate of their intrinsic value. AHR is the closer of the two: -416%, against -607% for SBRA.
Values as of the 22 Sept 2026 close.
Discounting its cash flows at 8.7% (average of 3 methods) values the shares at $10.01; the price of $51.69 is 416% above that value, and 78% of that value comes from beyond year five.
Leak Score 0/100 on 2 of 12 signals
Discounting its cash flows at 7.5% (average of 3 methods) values the shares at $2.80; the price of $19.81 is 607% above that value, and 81% of that value comes from beyond year five.
Leak Score 0/100 on 2 of 12 signals
| Metric | AHR | SBRA |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Price | $51.69 | $19.81 |
| Intrinsic value | $10.01 | $2.80 |
| Margin of safety | -416% | -607% |
| Leak Score | 0/100 (2/12) | 0/100 (2/12) |
| Market cap | $11.3B | $5.1B |
| Revenue growth, 5 years | 12.7% | 5.5% |
| Operating margin | 6.8% | 18.8% |
| Net margin | 4.8% | 7.6% |
| Return on equity | 4.0% | 2.4% |
| Debt to equity | 0.42 | 0.96 |
| P/E | 76.7x | 76.2x |
| Forward P/E | 65.8x | 25.9x |
| P/B | 2.7x | 1.8x |
| Dividend yield | 2.0% | 6.1% |